Mostrando 2 resultados de: 2
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
ReviewAbstract: inTrodUCTion: The management of non-metastatic castration-resistant prostate cancer (nmCrpC) has undPalabras claves:Apalutamide, Castration, Darolutamide, Enzalutamide, Network meta-analysis, prostatic neoplasmsAutores:Briganti A., Diego M. Carrión, Egawa S., Esperto F., Fiori C., Grossmann N.C., Katayama S., Kimura T., Laukhtina E., Mori K., Mostafaei H., Motlagh R.S., Papalia R., Ploussard G., Pradere B., Quhal F., Rajwa P., Schuettfort V.M., Shariat S.F.Fuentes:scopusTriggers for delayed intervention in patients with small renal masses undergoing active surveillance: A systematic review
ReviewAbstract: INTRODUCTION: Patients with small renal masses (SRM) can be exposed to overdiagnosis and overtreatmePalabras claves:Carcinoma, renal cell, Review, Watchful waitingAutores:Amparore D., Campi R., Capitanio U., Corti F., Diego M. Carrión, Esperto F., Fiori C., Kutikov A., Mari A., Minervini A., Mir M.C., Papalia R., Pierorazio P.M., Porpiglia F., Scarpa R.M., Serni S., Sessa F., Volpe A.Fuentes:scopus